|
N- [(3R,4R,5S,6R)- 2- [(2R,3S,4R,5S)- 5- Acetamido- 4- [(2R,3R,4S,5S,6R)- 3,5- dihydroxy- 6- (hydroxymethyl)- 4- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxyoxan- 2- yl]oxy- 2,3,6- trihydroxyhexoxy]- 4- hydroxy- 6- (hydroxymethyl)- 5- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxyoxan- 3- yl]acetamide |
|
CHEBI:151913 |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by a third party.
|
|
Gareth Owen
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C34H60N2O26/c1- 9(42) 35- 11(3- 37) 28(60- 34- 27(54) 30(21(48) 15(6- 40) 58- 34) 62- 33- 26(53) 24(51) 20(47) 14(5- 39) 57- 33) 18(45) 12(44) 8- 55- 31- 17(36- 10(2) 43) 22(49) 29(16(7- 41) 59- 31) 61- 32- 25(52) 23(50) 19(46) 13(4- 38) 56- 32/h11- 34,37- 41,44- 54H,3- 8H2,1- 2H3,(H,35,42) (H,36,43) /t11- ,12+,13+,14+,15+,16+,17+,18- ,19- ,20- ,21- ,22+,23- ,24- ,25+,26+,27+,28+,29+,30- ,31?,32- ,33- ,34- /m0/s1 |
GRPWBNSAQUBRBA-RUSYCGGMSA-N |
O1[C@@H] ([C@@H] (O[C@@H] 2O[C@@H] ([C@H] (O) [C@H] (O) [C@H] 2O) CO) [C@H] (O) [C@@H] (NC(=O) C) C1OC[C@@H] (O) [C@H] (O) [C@H] (O[C@@H] 3O[C@@H] ([C@H] (O) [C@H] (O[C@@H] 4O[C@@H] ([C@H] (O) [C@H] (O) [C@H] 4O) CO) [C@H] 3O) CO) [C@@H] (NC(=O) C) CO) CO |
|
Outgoing
|
N- [(3R,4R,5S,6R)- 2- [(2R,3S,4R,5S)- 5- Acetamido- 4- [(2R,3R,4S,5S,6R)- 3,5- dihydroxy- 6- (hydroxymethyl)- 4- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxyoxan- 2- yl]oxy- 2,3,6- trihydroxyhexoxy]- 4- hydroxy- 6- (hydroxymethyl)- 5- [(2S,3R,4S,5R,6R)- 3,4,5- trihydroxy- 6- (hydroxymethyl)oxan- 2- yl]oxyoxan- 3- yl]acetamide
(CHEBI:151913)
is a
N-acyl-hexosamine
(CHEBI:21656)
|
|
WURCS=2.0/3,5,4/[h2112h_2*NCC/3=O][a2112h- 1b_1- 5][a2122h- 1x_1- 5_2*NCC/3=O]/1- 2- 2- 3- 2/a3- b1_a6- d1_b3- c1_d4- e1
|
SUBMITTER
|
|